You are here: All Products  > Haisco Invests $10 Million in Pneuma Respiratory; Acquires Rights to Asthma/COPD Inhaler

Haisco Invests $10 Million in Pneuma Respiratory; Acquires Rights to Asthma/COPD Inhaler

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products